Expression of E-cadherin in oesophageal carcinomas from the UK and China: Disparities in prognostic significance

Journal of Clinical Pathology

Volumn 50, Issue 8, 1997, Pages 640-644

  Jian, Wei Guo ^a   Darnton, S Jane ^a   Jenner, Keely ^a   Billingham, Lucinda J ^b   Matthews, Hugoe R ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Cadherins; China; Oesophageal neoplasms

Indexed keywords

UVOMORULIN;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; CHINA; CLINICAL ARTICLE; DIAGNOSTIC VALUE; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; SURVIVAL TIME; UNITED KINGDOM;

EID: 0030827780     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.8.640     Document Type: Article

References (34)

1. Lewin KJ, Dawsey SM, Wang GQ. Squamous carcinoma of the esophagus in China and the West: are they different disorders? Dis Esophagus 1995;8:44-7.
2. Matthews HR, Waterhouse JAH, Powell J, McConkey CC, Robertson JE, eds. Overall survival. In: Clinical cancer monographs. Vol 1. Cancer of the oesophagus. London: Macmillan, 1987:62, 68, 78.
3. Kelsen DP. More or less surgery for esophageal cancer: non-operative therapy of esophageal cancer. Dis Esophagus 1994;7:162-8.
4. Takeichi M. The cadherins: cell cell adhesion molecules controlling animal morphogenesis. Development 1988;102: 639-55.
5. Pignatelli M. E-cadherin: a biological marker of tumour differentiation [editorial]. J Pathol 1993;171:81-2.
6. Behrens J. Cadherins as determinants of tissue morphology and suppressors of invasion. Acta Anat 1994;149:165-9.
7. Jiang WG, Puntis MCA, Hallett MB. Molecular and cellular basis of cancer invasion and metastasis: implications for treatment. Br J Surg 1994;81:1576-90.
8. Jankowski JA, Newham PM, Kandemir O, Hirano S, Takeichi M, Pignatelli M. Differential expression of E-cadherin in normal, metaplastic and dysplastic oesophageal mucosa: a putative biomarker. Int J Oncol 1994;4:441-8.
9. Shiozaki H, Oka H, Inoue M, Tamura S, Monden M. E-cadherin mediated adhesion system in cancer cells. Cancer 1996;77:1605-13.
10. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HFM, Debruyne FMJ, Schalken JA. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumours. Cancer Res 1993;53:3241-5.
11. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993;142:987-93.
12. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 1993;169:245-250.
13. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeir W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991;51:6328-37.
14. Vessey CJ, Wilding J, Folarin N, Hirano S, Takeichi M, Soutter P, et al. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 1995;176:151-9.
15. Nigam AK, Savage FJ, Boulos PB, Stamp GWH, Liu D, Pignatelli M. Loss of cell cell and cell matrix adhesion molecules in colorectal cancer. Br J Cancer 1993;68:507-14.
16. Sakuragi N, Nishiya M, Ikeda K, Ohkouch T, Furth EE, Hareyama H, et al. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecologic Oncol 1994;53:183-189.
17. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993;53:1690-5.
18. Katagiri A, Watanabe R, Tomita Y. E-cadherin expression in renal cell cancer and its significance in metastasis and survival. Br J Cancer 1995;71:376-9.
19. Böhm M, Totzeck B, Birchmeir W, Wieland I. Differences of E-cadherin expression levels and patterns in primary and metastatic human lung cancer. Clin Exp Metastasis 1994;12:55-62.
20. Pignatelli M, Ansari TW, Gunter P, Liu D, Hirano S, Takeichi M, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 1994; 174:243-8.
21. Otto T, Rembrink K, Goepel M, Meyer-Schwickerath M, Rübben H. E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma. Urol Res 1993;21:359-62.
22. Shiozaki H, Tahara H, Oka H, Miyata M, Kobayashi K, Tamura S, et al. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991;139:17-23
23. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, et al. E-cadherin and u-catenin expression in human esophageal cancer. Cancer Res 1994;54:291-6.
24. Miyata M, Shiozaki H, Iihara K, Shimaya K, Oka H, Kadowaki T, et al. Relationship between E-cadherin expression and lymph node metastasis in human esophageal cancer. Int J Oncol 1994;4:61-5.
25. Bongiorno PF, Al-Kasspooles M, Lee SW, Rachwal WJ, Moore JH, Whyte RI, et al. E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer 1995;71:166-72.
26. Swami S, Kumble S, Triadafilopoulos G. E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. Am J Gastroenterol 1995;90:1808-13.
27. Doki Y, Shiozaki H, Tahara H, Inoue M, Oka H, Iihara K, et al. Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line. Cancer Res 1993;53:3421-6.
28. Hermanek P, Sobin LH, eds. UICC International Union against Cancer. TNM classification of malignant tumours. 4th edn. 2nd rev. Berlin: Springer Verlag, 1992:42-4.
29. Everitt BS. The analysis of contingency tables. London: Chapman and Hall, 1977.
30. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, 1989.
31. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Russell SEH. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Cancer Res; 55:3406-11.
32. Vijeyasingam R, Darnton SJ, Jenner K, Allen CA, Billingham C, Matthews HR. Expression of p53 protein in oesophageal carcinoma: clinicopathological correlation and prognostic significance. Br J Surg 1994;81:1623-6.
33. Wang D-Y, Xiang Y-Y, Tanaka M, Li X-R, Li J-R, Shen Q, et al. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer 1994;74: 3089-96.
34. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert HE. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 1994;74:2218-23